LEIDEN, The Netherlands--(BUSINESS WIRE)--GenScript Biotech Europe BV announced that it has obtained CE marking for its SARS-CoV-2 diagnostic products to be sold as an in vitro diagnostic (“IVD”).
New Delhi: GenScript Biotech Corporation, a leading global biotechnology company today announced a strategic sales distribution agreement, appointing Premas Life Sciences (PLS) as the exclusive ...
LEIDEN, Netherlands & BILBAO, Spain--(BUSINESS WIRE)--GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading ...
PISCATAWAY, N.J., June 3, 2020 /PRNewswire/ -- GenScript Biotech Corp., the world's leading research reagent provider, announced today that the company has filed for Emergency Use Authorization (EUA) ...
PISCATAWAY, N.J., July 28, 2021 /PRNewswire/ — GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, ...
GenScript's latest at-home rapid test is designed to help individuals make better health decisions regarding SARS-CoV-2 exposure; it detects neutralizing antibodies in patients who have either been ...
GenScript Biotech Europe BV announced that it has obtained CE marking for its SARS-CoV-2 diagnostic products to be sold as an in vitro diagnostic ("IVD"). Among these products is the novel cPass TM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback